Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04497389 · ClinicalTrials.gov registry record · Phase 1
Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients
A Phase 1 study, sponsored by University of Utah.
- Completed
- Registry status
- Phase 1
- Development phase
- 47
- Enrollment target
NCT04497389 is a Phase 1 study that has completed, run by University of Utah. The registered enrollment target is 47 participants.
The verdict
NCT04497389, a Phase 1 study, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 47 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the effectiveness of processed human amniotic fluid as a treatment for COVID-19.
Interventions
- BIOLOGICAL Human Amniotic Fluid
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 47 participants |
| Start Date | 2020-10-28 |
| Est. Completion | 2023-02-15 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04497389
The ClinicalTrials.gov registry entry for NCT04497389 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 47 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Human Amniotic Fluid is the first listed.
NCT04497389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04497389 about?
NCT04497389 is a clinical study titled "Safety and Feasibility of Amniotic Fluid as a Treatment for COVID-19 Patients". The purpose of this study is to explore the effectiveness of processed human amniotic fluid as a treatment for COVID-19.
What is the current status of trial NCT04497389?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 47 participants. The study started on 2020-10-28. Estimated completion is 2023-02-15.
What interventions are being tested in trial NCT04497389?
The interventions under investigation include: Human Amniotic Fluid (BIOLOGICAL).
Who is sponsoring clinical trial NCT04497389?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.